IL-31 Rabbit Polyclonal Antibody

IL-31 Rabbit Polyclonal Antibody

To Order: garrett@bioworldantibodies.com

Polyclonal IL-31 Antibody

APR06392G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IL-31 . This antibody is tested and proven to work in the following applications:

IL-31 Polyclonal Antibody

ES8589-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against IL-31 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

IL-31 Polyclonal Antibody

ES8589-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against IL-31 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

XMIR-31 RNA oligo miRNA-31-5p with Xmotif

XMIR-31 10 rxn
EUR 525.6

AXMIR-31 RNA oligo anti-miRNA-31-5p with Xmotif

AXMIR-31 10 reactions
EUR 525.6

IL-31 Antibody

3745-002mg 0.02 mg
EUR 206.18
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

IL-31 Antibody

3745-01mg 0.1 mg
EUR 523.7
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

IL-31 Antibody

3747-002mg 0.02 mg
EUR 206.18
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

IL-31 Antibody

3747-01mg 0.1 mg
EUR 523.7
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

IL-31 Antibody

24390-100ul 100ul
EUR 468

IL-31 Antibody

24391-100ul 100ul
EUR 468

Rabbit IL-31 ELISA Kit

ERTI0041 96Tests
EUR 625.2

IL-31

E21-053 10ug
EUR 411.6

Anti-IL-31 Antibody

A08339-1 100ug/vial
EUR 400.8

Anti-IL-31 antibody

STJ98951 200 µl
EUR 236.4
Description: Rabbit polyclonal to IL-31.

XMIRXpress lentivector miRNA-31-5p with Xmotif

XMIRXP-31 10 ug
EUR 812.4

IL-31, Interleukin-31, human

RC212-42 2ug
EUR 125.26

Canine Interleukin 31(IL-31)

QY-E70194 96T
EUR 511.2

IL-31 Peptide

3745P 0.05 mg
EUR 197.7
Description: (NT) IL-31 peptide

IL-31 Peptide

3747P 0.05 mg
EUR 197.7
Description: (IN) IL-31 peptide

IL-31, Human

HY-P7217 50ug
EUR 914.4

Recombinant Human Interleukin-31/IL-31

C053-10ug 10ug
EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human Interleukin-31/IL-31

C053-1mg 1mg
EUR 3774
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human Interleukin-31/IL-31

C053-500ug 500ug
EUR 2660.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human Interleukin-31/IL-31

C053-50ug 50ug
EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

IL-20, Interleukin-20, human

RC212-31 2ug
EUR 125.26

Nori® Rabbit IL-31 ELISA Kit

GR144233 96-well
EUR 553.2

Anti-IL-31 alpha antibody

STJ96456 200 µl
EUR 236.4
Description: Rabbit polyclonal to IL-31Ralpha.

IL-31 Rabbit Polyclonal Antibody

Back To Top